ARROWHEAD PHARMACEUTICALS, INC. Deferred Tax Assets, Operating Loss Carryforwards, State and Local
ARROWHEAD PHARMACEUTICALS, INC. (ARWR) had Deferred Tax Assets, Operating Loss Carryforwards, State and Local of $37.90 million as of 2014-09-30, per its 10-K filed 2014-11-25.
Discontinued › Notes › Income Taxes › Components of Deferred Tax Assets and Liabilities › Deferred Tax Assets, Gross › Deferred Tax Assets, Operating Loss Carryforwards, Components
us-gaap:DeferredTaxAssetsOperatingLossCarryforwardsStateAndLocal · last filed 2014-11-25
- 2014-09-30: Deferred Tax Assets, Operating Loss Carryforwards, State and Local $37.90M.
- 2013-09-30: Deferred Tax Assets, Operating Loss Carryforwards, State and Local $80.00M; Deferred Tax Assets, Operating Loss Carryforwards, State and Local as first filed $32.60M.
- 2012-09-30: Deferred Tax Assets, Operating Loss Carryforwards, State and Local $77.40M; Deferred Tax Assets, Operating Loss Carryforwards, State and Local as first filed $75.90M.
| Period end | Deferred Tax Assets, Operating Loss Carryforwards, State and Local | Deferred Tax Assets, Operating Loss Carryforwards, State and Local as first filed |
|---|---|---|
| 2014-09-30 | $37.90M 10-K · filed 2014-11-25 | |
| 2013-09-30 | $80.00M 10-K · filed 2014-11-25 | $32.60M 10-K · filed 2013-12-18 |
| 2012-09-30 | $77.40M 10-K · filed 2013-12-18 | $75.90M 10-K · filed 2012-12-28 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| CYTOKINETICS INC (CYTK) | United States | $9.130B | -11.86 |
| Protagonist Therapeutics, Inc (PTGX) | United States | $8.883B | 95.52 |
| TG THERAPEUTICS, INC. (TGTX) | United States | $8.805B | 19.05 |
| Axsome Therapeutics, Inc. (AXSM) | United States | $10.274B | -66.82 |
| Praxis Precision Medicines, Inc. (PRAX) | United States | $7.884B | -27.60 |
| Structure Therapeutics Inc. (GPCR) | United States | $7.710B | -53.41 |
| Spyre Therapeutics, Inc. (SYRE) | United States | $7.685B | -43.69 |
| Elanco Animal Health Inc (ELAN) | United States | $11.177B | -61.80 |
| IONIS PHARMACEUTICALS INC (IONS) | United States | $7.277B | -23.25 |
| Alkermes plc. (ALKS) | $6.844B | 132.74 |